n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacin, F; Cellarier, E; Chollet, P; D'Incan, M; Durando, X; Farges, MC; Madelmont, JC; Mouret-Reynier, MA; Thivat, E; Vasson, MP | 1 |
| Bay, JO; Chazal, J; Chollet, P; Curé, H; Durando, X; Lemaire, JJ; Lentz, MA; Roché, H; Thivat, E; Verrelle, P | 1 |
| Barthomeuf, C; Cellarier, E; Chollet, P; D'Incan, M; Demidem, A; Durando, X; Farges, MC; Thivat, E; Vasson, MP | 1 |
3 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Glioma
| Article | Year |
|---|---|
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Choroid Neoplasms; Combined Modality Therapy; Diet; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Melanoma; Methionine; Middle Aged; Neoplasm Staging; Nitrosourea Compounds; Nutritional Status; Prognosis; Survival Rate; Treatment Outcome | 2009 |
Cystemustine in recurrent high grade glioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Prognosis; Survival Analysis; Survival Rate; Treatment Outcome | 2006 |
Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Male; Melanoma; Methionine; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Nutritional Status; Oligodendroglioma; Patient Compliance; Treatment Outcome | 2008 |